Abstract
Diabetes mellitus is a serious and complex metabolic disorder characterized by hyperglycemia. In recent years natural products has gained much more interest by researchers as alternative sources for diabetes treatment. Though many potential agents are identified so far but their clinical utility is limited because of their adverse effects. Therefore, there is a keen interest in discovering natural compounds to treat diabetes efficiently with less side effects. Dalbergia latifolia is well explored because of its diverse pharmacological activities including diabetes. Therefore, the present research work aimed to identify and isolate the potential antidiabetic agents from the heart wood of Dalbergia latifolia. We successfully extracted DGN and ISG from the heartwood and evaluated their antidiabetic potential both in-vivo and in-vitro. Alpha amylase activity inhibition of ISG and DGN was found to be 99.05 ± 8.54% (IC50 = 0.6025 µg/mL) and 84.68 ± 5.2% (IC50 = 0.0216 µg/mL) respectively. Glucose uptake assay revealed DGN (158%) promoted maximum uptake than ISG (77%) over control. In vivo anti diabetic activity was evaluated by inducing diabetes in SD rats with the help of HFD and STZ (35 mg/kg body weight). After the continuous administration of DGN (5 mg/kg, 10 mg/kg) and ISG (5 mg/kg, 10 mg/kg) for 14 days, we observed the reduction in the blood glucose levels, body weight, total cholesterol, low density lipoprotein, very low-density lipoprotein, blood urea, serum creatinine, serum glutamate oxaloacetic transaminase, serum glutamate pyruvate transaminase and alkaline phosphatase levels than vehicle group indicates the potency of ISG and DGN against diabetes.
Similar content being viewed by others
Data Availability
No datasets were generated or analysed during the current study.
Abbreviations
- ADMET:
-
Absorption, Distribution, Metabolism, Elimination, Toxicity
- ALP:
-
Alkaline phosphatase
- ANOVA:
-
Analysis of variance
- DGN:
-
Dalbergin; DL: Dalbergia Latifolia
- DM:
-
Diabetes mellitus
- DMEM:
-
Dulbecco’s modified eagle’s medium
- DPP-4:
-
Dipeptidyl peptidase 4
- EMA:
-
European Medical Agency
- FBS:
-
Fetal bovine serum
- GLP-1:
-
Glucose like peptide 1
- GLUT-4:
-
Glucose transporter 4
- GOD-POD:
-
Glucose oxidase and peroxidase
- HDL:
-
High density lipoprotein
- HFD:
-
High fat diet
- ISG:
-
Isoliquiritigenin
- LDL:
-
Low density lipoprotein
- NCCS:
-
National center for cell science
- NMR:
-
Nuclear magnetic resonance
- NRU:
-
Neutral red uptake
- PBS:
-
Phosphate buffer solution
- SC:
-
Serum creatinine
- SD:
-
Sprague Dawley
- SGOT:
-
Serum glutamic oxaloacetic transaminase
- SGPT:
-
Serum glutamate pyruvate transaminase
- STZ:
-
Streptozotocin
- T2D:
-
Type 2 diabetes
- TC:
-
Total cholesterol
- TG:
-
Triglycerides
- VLDL:
-
Very low-density lipoprotein
- WHO:
-
World health organization
References
Katovich, M. J., Meldrum, M. J., & Vasselli, J. R. (1991). Beneficial Effects of Dietary Acarbose in the Streptozotocin-Induced Diabetic Rat. Metabolism, 40(12), 1275–1282.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016). Pancreatic regulation of glucose homeostasis. Experimental and Molecular Medicine, 48(219), 1–19.
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018). Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomedicine and Pharmacotherapy, 107, 306–328.
Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., & Smith, A. E., et al. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 402, 203–234.
George, F., Cahill, J. M. D., Donnell, D., & Etzwiler, M. D. (1976). Norbert Freinkel M.D. Control and Diabetes. The New England Journal of Medicine, 294(18), 1004–1005.
Hinnen, D. A. (2015). Therapeutic options for the management of postprandial glucose in patients with type 2 diabetes on basal insulin. Clinical Diabetes, 33(4), 175–180.
Nellaiappan, K., Preeti, K., Khatri, D. K., & Singh, S. B. (2022). Diabetic complications: an update on pathobiology and therapeutic strategies. Current Diabetes Review, 18(1), 31–44.
Janardhan, S., & Narahari Sastry, G. (2014). Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment. Current Drug Targets, 15(6), 600–621.
Bragagni, A., Piani, F., & Borghi, C. (2021). Surprises in cardiology: Efficacy of gliflozines in heart failure even in the absence of diabetes. European Heart Journal, Supplement, 23, 40–E44.
Salama, M., Mohammed Ezzat, S., & salem, M. (2020). Bioactive lead compounds and molecular targets for the treatment of heart disease. Phytochemicals as Lead Compounds for New Drug Discovery, 488, 1–381.
Mirmiran, P., Bahadoran, Z., & Azizi, F. (2014). Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review. World Journal of Diabetes, 5(3), 267–281.
Tundis, R., Loizzo, M. R., & Menichini, F. (2010). Natural Products as -Amylase and -Glucosidase Inhibitors and their Hypoglycaemic Potential in the Treatment of Diabetes: An Update. Mini-Reviews in Medicinal Chemistry, 10(4), 315–331.
Mojsov K. D. Aspergillus Enzymes for Food Industries. Aspergillus Enzymes for Food Industries. New and Future Developments in Microbial Biotechnology and Bioengineering. Elsevier B.V.; 2016. p. 215–222
Vasudeva, N., Vats, M., Sharma, S. K., & Sardana, S. (2009). Chemistry and Biological Activities of the Genus Dalbergia-A Review. Pharmacognosy Review, 3(6), 307–319.
Soudahmini, E., Senthil, G. M., Panayappan, L., & Divakar, M. C. (2005). Herbal remedies of Madugga tribes of Siruvani forest, South India. Natural Product Radiance, 4(6), 492–499.
Martha, R., Mubarok, M., Darmawan, W., Syafii, W., Dumarcay, S., & Charbonnier, C. G., et al. (2021). Biomolecules of interest present in the main industrial wood species used in indonesia-a review. Journal of Renewable Materials, 9(3), 399–449.
Padal S. B., Prayaga Murty P., Rao D. S., Venkaiah M. Ethnomedicinal plants from paderu division of visakhapatnam district, A.P, India. Journal of Phytology [Internet]. 2010(8):70–91. Available from: www.journal-phytology.com
Panda, S. K. (2014). Ethno-medicinal uses and screening of plants for antibacterial activity from Similipal Biosphere Reserve, Odisha, India. Journal of Ethnopharmacology, 151(1), 158–175.
Syafii, W.(2000). Antitermitic compounds from the heartwood of Sonokeling wood (Dalbergia latifolia Roxb.). Indonesian Journal of Tropical Agriculture (IJTA), 9(03), 55–58.
Daryatmo, J., Hartadi, H., Orskov, E. R., Adiwimarta, K., & Nurcahyo, W. (2010). In vitro screening of various forages for anthelmintic activity on Haemonchus contortus eggs. Advances in Animal Biosciences, 1(1), 113.
Kulkarni, S. C., Pkm, N., Sainadh, N. S., & Vasanthakumar, C. (2013). Evaluation of Cerebroprotective Effect of Flavonoid of Dalbergia Latifolia Against Cerebral Ischemia Re-Perfusion Induced Cerebral Infarction in Rats by BCCAO Method. RRJPTS, 1(1), 8–14.
Khalid, M., Shoaib, A., Akhtar, J., Alqarni, M. H., Siddiqui, H. H., & Foudah, A. I. (2020). Anti obesity prospective of Dalbergia latifolia (Roxb.) hydroalcoholic bark extract in high fat diet induced obese rats. 3 Biotech, 10(11), 1–12.
Niwa, Y., Matsui, C., Sukumwang, N., Iinuma, H., Ikeda, Y., & Koyano, T., et al. (2012). Inhibition of lysenin-induced hemolysis by all-E-lutein derived from the plant Dalbergia latifolia. Planta Medicine, 78(10), 957–961.
Yadav, S. K., Nagarathna PKM, & Yadav, C. K. (2015). Research article of evaluation of immunomodulatory activity of Dalbergia latifolia on Swiss albino mice. Journal of Pharmaceutical Biological & Science, 10, 58–64.
Prasad, D. P., Suba, V., kavimani, S., & Ravichandran, V. (2013). Neuropharmacological profile of ethanolic extract of dalbergia latifolia roxb in swiss albino mice. JGTPS, 4(3), 1193–1197.
Pkm, N., Kumar Yadav, C., & Kumar Yadav, S. (2015). Evaluation of Mutagenic Effect (Antimutagenic) of Dalbergia Latifolia on Swiss Albino Mice. IJPTR, 7(2), 80–84.
Tiwari, A., & Choudhary, N. K. (2021). Phytopharmacological evaluation of dalbergia latifolia roxb. for antidiabetic activity and its effect on lipid profile and hepatic enzymes of glucose metabolism in diabetic rats. Journal of Advanced Science Research, 12(3), 95–109.
Jemiseye, O. T., Idowu, P. A., & Agidigbi, T. S. (2017). In vitro Assessment of Selected Antibiotics, Crude Extract of Dalbergia latifolia Leaf and Their Combination on MDR Salmonella enterica Strain. Journal of Complementary and Alternative Medical Research, 4(3), 1–9.
Mishra, M. P., & Padhy, R. N. (2013). In vitro antibacterial efficacy of 21 Indian timber-yielding plants against multidrug-resistant bacteria causing urinary tract infection. Osong Public Health Research Perspective, 4(6), 347–357.
Tripathi, R. (2018). In Vitro Α-Glucosidase Inhibitory Potential and Free Radical Quenching Activity of Some Selected Medicinal Plants Total Poly Phenolic Content and Its Pharmacological Activity of Medicinal Plant. JETIR, 5(7), 538–548.
Donnelly, D. M., Criodain, T. O., & O’ Sullivan, M. (1983). Dalbergia species: XV. dalcriodain, a binary neoflavanoid. In Proceedings of the Royal Irish Academy. Section B: Biological, Geological, and Chemical Science. pp. 39–48.
Udomputtimekakul, P., Pompimon, W., Baison, W., Sombutsiri, P., Funnimid, N., & Chanadee, A., et al. (2017). Profiling of secondary metabolites in aerial parts of phanera bracteata. American Journal of Plant Science, 08(05), 1100–1134.
Khamsan, S., Liawruangrath, S., Teerawutkulrag, A., Pyne, S., Garson, M., & Liawruangrath, B. (2012). The isolation of bioactive flavonoids from Jacaranda obtusifolia H. B. K. ssp. rhombifolia (G. F. W. Meijer) Gentry. Acta Pharmaceutica, 62(2), 181–190.
Sano, S., Okubo, Y., Handa, A., Nakao, M., Kitaike, S., & Nagao, Y., et al. (2011). Reinvestigation of the Synthesis of Isoliquiritigenin: Application of Horner-Wadsworth-Emmons Reaction and Claisen-Schmidt Condensation. Chemical and Pharmaceutical Bulletin, 59(7), 885–888.
Ma, C. J., Li, G. S., Zhang, D. L., Liu, K., & Fan, X. (2005). One step isolation and purification of liquiritigenin and isoliquiritigenin from Glycyrrhiza uralensis Risch. using high-speed counter-current chromatography. Journal of Chromatography A, 1078, 188–192.
Visvanathan, R., Jayathilake, C., Liyanage, R., & Sivakanesan, R. (2018). Applicability and reliability of the glucose oxidase method in assessing α-amylase activity. Food Chemistry, 275(3), 1–29.
Yap, A., Nishiumi, S., Yoshida, K. I., & Ashida, H. (2007). Rat L6 myotubes as an in vitro model system to study GLUT4-dependent glucose uptake stimulated by inositol derivatives. Cytotechnology, 55, 103–108.
Cudazzo, G., Smart, D. J., McHugh, D., & Vanscheeuwijck, P. (2019). Lysosomotropic-related limitations of the BALB/c 3T3 cell-based neutral red uptake assay and an alternative testing approach for assessing e-liquid cytotoxicity. Toxicology in Vitro, 61, 1–8.
Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C. L., & Ramarao, P. (2005). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacology Research, 52(4), 313–320.
Volcko, K. L., Carroll, Q. E., Brakey, D. J., & Daniels, D. (2020). High-fat diet alters fluid intake without reducing sensitivity to glucagon-like peptide-1 receptor agonist effects. Physiology Behaviour, 221(112β910), 1–9.
Kong, W., Sun, R., Gao, Y., Nan, G., Yang, G., & Li, Y. (2015). Dissociation Constants and Solubilities of Dalbergin and Nordalbergin in Different Solvents. Journal of Chemical & Engineering Data, 60(9), 2585–2593.
Tadera, K., Minami, Y., Takamatsu, K., & Matsuoka, T. (2006). Inhibition of alpha glucosidase and alpha amylase by flavonoids. Journal of Nutritional Science Vitaminology, 52(2), 149–153.
Borenfreund, E., & Puerner, J. A. (1985). A simple quantitative procedure using monolayer cultures for cytotoxicity assays. Journal of tissue culture methods, 9(1), 7–9.
van de Venter, M., Roux, S., Bungu, L. C., Louw, J., Crouch, N. R., & Grace, O. M., et al. (2008). Antidiabetic screening and scoring of 11 plants traditionally used in South Africa. Journal of Ethnopharmacology, 119(1), 81–86.
Tortorella, L. L., & Pilch, P. F. (2002). C2C12 myocytes lack an insulin-responsive vesicular compartment despite dexamethasone-induced GLUT4 expression. American Journal of Physiology Endocrinology Metabolism, 283(3), e514–e524.
Zheng, Y., Scow, J. S., Duenes, J. A., & Sarr, M. G. (2012). Mechanisms of glucose uptake in intestinal cell lines: Role of GLUT2. Surgery, 151(1), 13–25.
Gupta, R. N., Pareek, A., Manish Suthar, Rathore, G., & Basniwal, P. K. (2009). Study of glucose uptake activity of Helicteres isora Linn. fruits in L-6 cell lines. International Journal of Diabetes in Developing Countries, 29(4), 172–176.
Al-Goblan, A. S., Al-Alfi, M. A., & Khan, M. Z. (2014). Mechanism linking diabetes mellitus and obesity. Diabetes Metabolic Syndrome Obesity, 7, 587–591.
Chang, W. C., Wu, J. S. B., Chen, C. W., Kuo, P. L., Chien, H. M., & Wang, Y. T., et al. (2015). Protective effect of vanillic acid against hyperinsulinemia, hyperglycemia and hyperlipidemia via alleviating hepatic insulin resistance and inflammation in High-Fat Diet (HFD)-fed rats. Nutrients, 7, 9946–9959.
Nambirajan, G., Karunanidhi, K., Ganesan, A., Rajendran, R., Kandasamy, R., & Elangovan, A., et al. (2018). Evaluation of antidiabetic activity of bud and flower of Avaram Senna (Cassia auriculata L.) In high fat diet and streptozotocin induced diabetic rats. Biomedicine and Pharmacotherapy, 108, 1495–1506.
Gaur, R., Yadav, K. S., Verma, R. K., Yadav, N. P., & Bhakuni, R. S. (2014). In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. Phytomedicine, 21, 415–422.
Pandey, N. K., Singh, S. K., Kumar, B., Gulati, M., Vishwas, S., & Khursheed, R., et al. (2022). Expanding arsenal against diabetes mellitus through nanoformulations loaded with glimepiride and simvastatin: A comparative study. Environmental Science and Pollution Research, 29(34), 1–21.
Joerin, L., Kauschka, M., Bonnländer, B., Pischel, I., Benedek, B., & Butterweck, V. (2014). Ficus carica leaf extract modulates the lipid profile of rats fed with a high-fat diet through an increase of HDL-C. Phytotherapy Research, 28(2), 261–267.
Sankeerthi C H, S. L. V., Biri, S. R. K., Rani T, S., Gundu, R., & Vadlakonda, A. (2021). A study on evaluating blood urea and serum creatinine in diabetes mellitus patients. International Journal of Clinical Biochemistry and Research, 8(4), 285–288.
Han, H. S., Kang, G., Kim, J. S., Choi, B. H., & Koo, S. H. (2016). Regulation of glucose metabolism from a liver-centric perspective. Experimental & Molecular Medicine, 48, 1–10.
Graham, D. S., Liu, G., Arasteh, A., Yin, X. M., & Yan, S. (2023). Ability of high fat diet to induce liver pathology correlates with the level of linoleic acid and Vitamin E in the diet. PLoS One, 18(6), 1–15.
Bae, C. S., Lee, Y., & Ahn, T. (2023). Therapeutic treatments for diabetes mellitus-induced liver injury by regulating oxidative stress and inflammation. Applied Microscopy, 53(4), 1–11.
Cao, W., Liu, H. Y., Hong, T., & Liu, Z. (2009). Excess exposure to insulin may be the primary cause of insulin resistance. American Journal of Physiology-Endocrinology Metabolism, 298(2), 1–1.
Kaur J., Gulati M., Kumar Pandey N., Lal Khatik G., Alotaibi F., Kumar D., et al. (2023). Antidiabetic evaluation of vanillic acid-glyburide loaded polymeric micelles in high fat diet and streptozotocin induced diabetic rats. Research Square.
Author information
Authors and Affiliations
Contributions
S.S. done all the research work and wrote the manuscript, R.S. and G.P. edited and reviewed the manuscript. H.V. and S.M. contributed in writing manuscript, K.C. helped to get the spectral data for the phytochemical components. N.K. and B.K. are helped for the pharmacological activity testing experiments.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sutrapu, S., Pal, R.S., Khurana, N. et al. Diabetes Warriors from Heart Wood: Unveiling Dalbergin and Isoliquiritigenin from Dalbergia latifolia as Potential Antidiabetic Agents in-vitro and in-vivo. Cell Biochem Biophys (2024). https://doi.org/10.1007/s12013-024-01285-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s12013-024-01285-x